Identifying and Solving Top Challenges to Oncology Biomarker TestingVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. David Rimm and Roy Herbst identify the top challenges in the area of biomarker testing as well as solutions to these challenges, including availability of sufficient tissue for a large number of biomarker assays, the time some biomarker tests require for completion, the need for a tight association of test results with clinical outcomes, and the development of companion diagnostics for certain immunotherapies.
Jayson Slotnik discusses the cost structure of diagnostics and pharmaceuticals in personalized medicine
Listen as Atheer Kaddis discusses the additional services that pharmacies can prescribe to patients with polycythemia vera and their families.Supported through funding from Incyte